-logo-1200x675.png?v=20261007110104){kind=logo}
VestGen Advisors LLC trimmed its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 19.8% during the 3rd quarter, Holdings Channel reports. The firm owned 25,927 shares of the company’s stock after selling 6,381 shares during the period. VestGen Advisors LLC’s holdings in Procter & Gamble were worth $3,767,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Procter & Gamble during the second quarter valued at $27,862,105,000. Bank of America Corp DE purchased a new stake in Procter & Gamble in the 2nd quarter worth $3,850,628,000. Bank of New York Mellon Corp purchased a new stake in Procter & Gamble in the 2nd quarter worth $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Procter & Gamble during the 2nd quarter valued at about $1,480,650,000. Finally, Corient Private Wealth LP bought a new position in shares of Procter & Gamble during the 2nd quarter valued at about $335,908,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Quarterly beat supports the stock: P&G reported earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion exceeded expectations. Sales increased 4% year over year, helping reinforce confidence in the company’s growth outlook. What Did Procter & Gamble’s Latest Quarter Change for Its Stock?
- Positive Sentiment: Analyst upgrade adds support: Freedom Broker raised its rating on PG from “hold” to “buy,” signaling increased confidence in the company’s earnings durability and valuation potential. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Revenue growth and dividend appeal remain key attractions: Organic sales rose 4%, with much of the gain coming from higher product volumes. P&G’s portfolio of leading brands and long dividend history continue to appeal to income-focused investors. Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
- Neutral Sentiment: New bond issuance highlights financing strategy: P&G tapped euro and dollar markets with fixed-rate notes, providing funding flexibility but also adding debt obligations. The issuance puts greater focus on the company’s balance sheet and already elevated valuation. Procter & Gamble Bond Sale Puts Its Pricey Valuation Narrative In Focus
- Negative Sentiment: Cost inflation and mixed ratings temper optimism: Rising commodity and operating costs could pressure margins, while DZ Bank downgraded PG from “strong-buy” to “hold.” ETF net selling also represents a modest technical headwind. How Is Procter & Gamble Handling Commodity Costs After Its Report?
Insider Transactions at Procter & Gamble
In related news, insider Balaji Purushothaman sold 4,181 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $160.71, for a total value of $671,928.51. Following the sale, the insider directly owned 11,296 shares of the company’s stock, valued at $1,815,380.16. This represents a 27.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Paul Gama sold 4,331 shares of the firm’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $161.27, for a total transaction of $698,460.37. Following the completion of the sale, the chief executive officer directly owned 46,793 shares of the company’s stock, valued at approximately $7,546,307.11. The trade was a 8.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 58,647 shares of company stock worth $9,268,508. 0.23% of the stock is currently owned by insiders.
Procter & Gamble Trading Up 1.4%
Shares of PG stock opened at $160.48 on Friday. The company has a market cap of $371.95 billion, a PE ratio of 24.17, a price-to-earnings-growth ratio of 3.89 and a beta of 0.39. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The stock’s 50 day simple moving average is $149.62 and its two-hundred day simple moving average is $148.85. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. During the same quarter in the previous year, the business earned $1.99 EPS. The company’s quarterly revenue was up 4.0% on a year-over-year basis. Research analysts predict that Procter & Gamble Company will post 6.99 earnings per share for the current year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio is currently 65.51%.
Analyst Ratings Changes
PG has been the topic of a number of research analyst reports. TD Cowen boosted their target price on Procter & Gamble from $150.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, October 23rd. DZ Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. HSBC downgraded Procter & Gamble from a “buy” rating to a “hold” rating and lowered their target price for the company from $182.00 to $149.00 in a research report on Thursday, July 30th. Freedom Broker upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 price target on the stock in a research report on Friday, October 23rd. Finally, UBS Group set a $166.00 price target on shares of Procter & Gamble in a research note on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $170.57.
View Our Latest Research Report on Procter & Gamble
About Procter & Gamble
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Read More
- Five stocks we like better than Procter & Gamble
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
